NBD AI Bulletin - Walvax Biotechnology Co Ltd (SZ 300142, close price: 44.01 yuan) announced on August 10 that the company plans to issue convertible notes worth no more than about 1.235 billion yuan. The convertible notes have a maturity of six years.
For 2021, the operating income of Walvax Biotechnology mainly came from proprietary vaccines (99.01%) and intermediate products (0.69%).
Walvax Biotechnology Co Ltd's chairman is Li Yunchun, male, 60 years old, with an undergraduate degree. The president is Jiang Runsheng, male, 65 years old, with a PhD degree.
As at the press time, the market value of Walvax Biotechnology Co Ltd was 70.5 billion yuan.
(By Lan Suying)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.